Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effect of topical diclofenac 3% and calcitriol 3 μg/g on superficial basal cell carcinoma (sBCC) and nodular basal cell carcinoma (nBCC): A phase II, randomized controlled trial
Tjinta Brinkhuizen, Kiki J.A. Frencken, Patty J. Nelemans, et al.
Journal of the American Academy of Dermatology (2016) Vol. 75, Iss. 1, pp. 126-134
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Drug repurposing in cancer
Linda Sleire, Hilde Elise Førde, Inger Anne Netland, et al.
Pharmacological Research (2017) Vol. 124, pp. 74-91
Closed Access | Times Cited: 307
Vitamin D Signaling in Inflammation and Cancer: Molecular Mechanisms and Therapeutic Implications
Ahmed M Elsharkawy, Ahmed Malki
Molecules (2020) Vol. 25, Iss. 14, pp. 3219-3219
Open Access | Times Cited: 148
Keratinocyte Carcinomas: Current Concepts and Future Research Priorities
Priyadharsini Nagarajan, Maryam M. Asgari, Adèle C. Green, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 8, pp. 2379-2391
Open Access | Times Cited: 120
Repurposing vitamin D for treatment of human malignancies via targeting tumor microenvironment
Xu Wu, Wei Hu, Lan Lu, et al.
Acta Pharmaceutica Sinica B (2018) Vol. 9, Iss. 2, pp. 203-219
Open Access | Times Cited: 116
A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery
Thanigaimalai Pillaiyar, Sangeetha Meenakshisundaram, Manoj Manickam, et al.
European Journal of Medicinal Chemistry (2020) Vol. 195, pp. 112275-112275
Open Access | Times Cited: 115
Targeting WNT Signaling for Multifaceted Glioblastoma Therapy
Matthew McCord, Yoh‐suke Mukouyama, Mark R. Gilbert, et al.
Frontiers in Cellular Neuroscience (2017) Vol. 11
Open Access | Times Cited: 98
Basal cell carcinoma pathogenesis and therapy involving hedgehog signaling and beyond
Anshika Bakshi, Sandeep Chaudhary, Mehtab Rana, et al.
Molecular Carcinogenesis (2017) Vol. 56, Iss. 12, pp. 2543-2557
Open Access | Times Cited: 93
British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021*
I. Nasr, Eric McGrath, Catherine Α. Harwood, et al.
British Journal of Dermatology (2021) Vol. 185, Iss. 5, pp. 899-920
Open Access | Times Cited: 80
S2k Guidelines for Cutaneous Basal Cell Carcinoma – Part 2: Treatment, Prevention and Follow‐up
Berenice M. Lang, Panagiotis Balermpas, Andrea Bauer, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2019) Vol. 17, Iss. 2, pp. 214-230
Open Access | Times Cited: 79
Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects
Roohi Mohi-ud-din, Apporva Chawla, Pooja Sharma, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 32
Interventions for basal cell carcinoma of the skin
Jason Thomson, Sarah Hogan, Jo Leonardi‐Bee, et al.
Cochrane library (2020) Vol. 2020, Iss. 12
Open Access | Times Cited: 67
The Role of Classical and Novel Forms of Vitamin D in the Pathogenesis and Progression of Nonmelanoma Skin Cancers
Andrzej Słomiński, Anna A. Brożyna, Michał A. Żmijewski, et al.
Advances in experimental medicine and biology (2020), pp. 257-283
Open Access | Times Cited: 50
Targeting the Oncoprotein Smoothened by Small Molecules: Focus on Novel Acylguanidine Derivatives as Potent Smoothened Inhibitors
Silvia Pietrobono, Barbara Stecca
Cells (2018) Vol. 7, Iss. 12, pp. 272-272
Open Access | Times Cited: 41
Advances in Topical Treatments of Cutaneous Malignancies
Yanci A. Algarin, Anokhi Jambusaria‐Pahlajani, Emily S. Ruiz, et al.
American Journal of Clinical Dermatology (2022) Vol. 24, Iss. 1, pp. 69-80
Closed Access | Times Cited: 21
Nonsurgical Treatments for Nonmelanoma Skin Cancer
Alexandra Collins, Jessica A. Savas, Laura Doerfler
Dermatologic Clinics (2019) Vol. 37, Iss. 4, pp. 435-441
Closed Access | Times Cited: 33
S2k‐Leitlinie Basalzellkarzinom der Haut – Teil 2: Therapie, Prävention und Nachsorge
Berenice M. Lang, Panagiotis Balermpas, Andrea Bauer, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2019) Vol. 17, Iss. 2, pp. 214-231
Closed Access | Times Cited: 30
Recent Advances in Signaling Pathways Comprehension as Carcinogenesis Triggers in Basal Cell Carcinoma
Mircea Tampa, Simona Roxana Georgescu, Cristina Iulia Mitran, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 3010-3010
Open Access | Times Cited: 28
Interventions for basal cell carcinoma: abridged Cochrane systematic review and GRADE assessments
Jason Thomson, Sarah Hogan, Jo Leonardi‐Bee, et al.
British Journal of Dermatology (2021) Vol. 185, Iss. 3, pp. 499-511
Open Access | Times Cited: 20
Nonsurgical treatment of nonmelanoma skin cancer in the mature patient
Romana Čeović, Mikela Petković, Zrinka Bukvić Mokoš, et al.
Clinics in Dermatology (2017) Vol. 36, Iss. 2, pp. 177-187
Closed Access | Times Cited: 22
Topical and Intralesional Immunotherapy for the Management of Basal Cell Carcinoma
Aurora Fernández-Galván, Pedro Rodríguez‐Jiménez, B. González‐Sixto, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2135-2135
Open Access | Times Cited: 2
Topical Delivery of Hedgehog Inhibitors: Current Status and Perspectives
Kristian Kåber Pedersen, Maria Høyer-Hansen, Thomas Litman, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14191-14191
Open Access | Times Cited: 10
Topical Sinecatechins, 10%, Ointment for Superficial Basal Cell Carcinoma
J.P.H.M. Kessels, Lotte M. Voeten, Patty J. Nelemans, et al.
JAMA Dermatology (2017) Vol. 153, Iss. 10, pp. 1061-1061
Open Access | Times Cited: 15
Diclofenac-Derived Hybrids for Treatment of Actinic Keratosis and Squamous Cell Carcinoma
Silvia Tampucci, Sara Carpi, Maria Digiacomo, et al.
Molecules (2019) Vol. 24, Iss. 9, pp. 1793-1793
Open Access | Times Cited: 15
Neoplastic Multifocal Skin Lesions: Biology, Etiology, and Targeted Therapies for Nonmelanoma Skin Cancers
Ana Rita Fernandes, Ana Cláudia Paiva‐Santos, Elena Sánchez‐López, et al.
Skin Pharmacology and Physiology (2017) Vol. 31, Iss. 2, pp. 59-73
Closed Access | Times Cited: 14
Alternative Behandlungsoptionen beim Basalzellkarzinom am Auge
Vinodh Kakkassery, Steffen Emmert, Irenäus A. Adamietz, et al.
Der Ophthalmologe (2019) Vol. 117, Iss. 2, pp. 113-123
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top